カテゴリー： 世界, 医療/バイオ, Grand View Research

組織診断の世界市場2023-2030：市場規模、シェア、動向分析

【英語タイトル】Tissue Diagnostics Market Size, Share & Trends Analysis Report By Technology (ISH, Digital Pathology), By Application (Breast Cancer, Prostate Cancer), By End-use, By Region, And Segment Forecasts, 2023 - 2030

Grand View Researchが出版した調査資料（GRV23SEP068）・商品コード：GRV23SEP068
・発行会社（調査会社）：Grand View Research
・発行日：2023年8月
・ページ数：180
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：グローバル
・産業分野：臨床診断
◆販売価格オプション（消費税別）
Single UserUSD5,950 ⇒換算￥904,400見積依頼/購入/質問フォーム
Multi User/Five UserUSD6,950 ⇒換算￥1,056,400見積依頼/購入/質問フォーム
Global/corporate LicenseUSD8,950 ⇒換算￥1,360,400見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

組織診断市場の成長と動向
Grand View Research, Inc.の最新レポートによると、世界の組織診断市場規模は2030年までに89億9000万米ドルに達し、2023年から2030年までのCAGRは7.15%で成長する見込みです。熟練病理医の不足による自動組織診断システムに対する需要の加速が、組織診断業界を牽引しています。侵襲的診断の必要性を最小化する自家蛍光などの高度なイメージング技術の出現が、市場成長をさらに補足しています。

デジタルスライドの使用は、フレキシブルな拡大やスライドへのリモートアクセスなど、その関連する利点により、近年大幅に増加しています。精密医療への関心の高まりは、米国の複数の組織や企業によって支えられており、市場の成長に貢献すると期待されています。さらに、各企業は新しい腫瘍学ソリューションで精密医療の開発を支援しています。例えば、2020年5月、QIAGEN社は腫瘍のゲノムプロファイリングソフトウェアソリューションQCI Interpret Oneなどの新しい腫瘍学ソリューションを発表しました。画像診断技術の進歩は、市場成長にプラスの影響を与えると予想されます。

さらに、組織診断業界の新たなトレンドの1つは、デジタル病理学と人工知能（AI）の統合です。デジタル病理学では、組織スライドのスキャンとデジタル化を行い、病理医が遠隔で画像を確認・分析できるようにします。その後、AIアルゴリズムをこれらのデジタル画像に適用することで、組織サンプルの解釈と分析を支援することができます。この統合により、より迅速で正確な診断が可能になり、ワークフローの効率が向上し、患者ケアの改善につながります。また、予測モデルや精密医療アプローチの開発も容易になります。その結果、市場ではデジタル病理学ソリューションとAI主導型組織診断プラットフォームに対する需要が高まっています。

画像診断技術の技術向上により、乳がんの検出・診断感度も向上しています。例えば、2023年5月、AIによる乳がん診断に重点を置き、BPGbioは最近、国防総省（DoD）との合意を発表しました。人工知能を用いて作成されたこの新しいパネルは、ER+乳がんと診断されたもののホルモン療法に反応しない女性を検出し、より適切な治療選択肢を可能にし、治療効果を向上させることを目的としています。

また、BPGbioのユニークな34遺伝子乳がん診断パネルは、Interrogative Biology Platformを通じて、著しく増加しているER+乳がんに焦点を当てた幅広い評価を受ける予定です。デジタル法、トモシンセシス法、CAD法などを用いた遺伝子発現、細胞生化学、分子生物学的評価など、乳房組織分析の技術的拡大。

組織診断市場レポートハイライト

- 2022年の組織診断業界では、IHC分野が最大シェアを占めました。IHC検査は精度が高く、異なるタイプのがん間の差異を識別するのに役立つため、採用率が高く、その結果、最大の収益シェアを獲得しました。

- デジタル病理学およびワークフロー分野は、調査期間中に最も速いCAGRで成長する見込みです。画像をデジタル化するための高度なインフラ整備への投資が増加し、デジタル病理学分野を牽引すると予想されます。さらに、熟練病理医の不足に起因する自動化モダリティの需要の増加が、この成長をさらに促進します。

- 乳がん症例の多さと、乳がん検出のための病理組織学的サンプルへのデジタル画像処理技術の応用の増加が、組織診断産業の最大シェアに貢献しました。

- 組織診断ソリューションの高い採用率により、2022年の組織診断業界は病院セグメントが支配的です。これらのソリューションは、従来の検査手順よりも正確な結果を最短時間で提供しています。

- 製薬企業やバイオテクノロジー企業が製品ラインナップを拡大するために提携を進めていることから、2022年の組織診断業界の売上高シェアは北米が最多です。

- Abbott、QIAGEN、Roche、Siemens、Danaher、Thermo Fisher、Merckがこの市場に参入している主要企業です。主要ベンダーは、市場での収益シェアを維持するために、新規製品の開発、提携、買収モデルに取り組んでいます。

第1章．調査手法＆範囲
第2章．エグゼクティブサマリー
第3章．市場変動・動向・範囲
第4章．技術別分析
第5章．用途別分析
第6章．エンドユーザー別分析
第7章．地域別分析
第8章．競争状況

グローバル市場調査レポート販売サイトのwww.marketreport.jpです。

❖ レポートの目次 ❖

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.1.1. Segment Definitions
1.1.1.1. Application Segment
1.1.1.2. Technology Segment
1.1.1.3. End-use Segment
1.2. Regional Scope
1.3. Estimates and Forecast Timeline
1.3.1. Objectives
1.3.2. Objective – 1
1.3.3. Objective – 2
1.3.4. Objective – 3
1.4. Research Methodology
1.5. Information Procurement
1.5.1. Purchased Database
1.5.2. GVR’s Internal Database
1.5.3. Secondary Sources
1.5.4. Primary Research
1.6. Information or Data Analysis
1.6.1. Data Analysis Models
1.7. Market Formulation & Validation
1.8. Model Details
1.8.1. Commodity Flow Analysis
1.9. List of Secondary Sources
1.10. List of Abbreviations
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Technology & Application Snapshot
2.3. End-use Snapshot
2.4. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Worldwide increase in cancer prevalence
3.2.1.2. Advancements in imaging techniques and increasing affordability of diagnostics
3.2.1.3. Growth of personalized therapeutics and diagnostics
3.2.2. Market Restraint Analysis
3.2.2.1. High costs associated with R&D and clinical trials
3.2.2.2. Presence of a non-value-based reimbursement policy
3.3. Industry Analysis Tools
3.3.1. Porter’s Five Forces Analysis
3.3.2. PESTEL Analysis
Chapter 4. Technology Business Analysis
4.1. Tissue Diagnostics Market: Technology Movement Analysis
4.2. Immunohistochemistry
4.2.1. Immunohistochemistry Market, 2018 – 2030 (USD Million)
4.2.2. Instruments
4.2.2.1. Instruments Market, 2018 – 2030 (USD Million)
4.2.2.2. Slide Staining Systems
4.2.2.2.1. Slide Staining Systems Market, 2018 – 2030 (USD Million)
4.2.2.3. Tissue Microarrays
4.2.2.3.1. Tissue Microarrays Market, 2018 – 2030 (USD Million)
4.2.2.4. Tissue Processing Systems
4.2.2.4.1. Tissue Processing Systems Market, 2018 – 2030 (USD Million)
4.2.2.5. Slide Scanners
4.2.2.5.1. Slide Scanners Market, 2018 – 2030 (USD Million)
4.2.2.6. Other Products
4.2.2.6.1. Other Products Market, 2018 – 2030 (USD Million)
4.2.3. Consumables
4.2.3.1. Consumables Market, 2018 – 2030 (USD Million)
4.2.3.2. Antibodies
4.2.3.2.1. Antibodies Market, 2018 – 2030 (USD Million)
4.2.3.3. Reagents
4.2.3.3.1. Reagents Market, 2018 – 2030 (USD Million)
4.2.3.4. Kits
4.2.3.4.1. Kits Market, 2018 – 2030 (USD Million)
4.3. In situ Hybridization
4.3.1. In situ Hybridization Market, 2018 – 2030 (USD Million)
4.3.2. Instruments
4.3.2.1. Instruments Market, 2018 – 2030 (USD Million)
4.3.3. Consumables
4.3.3.1. Consumables Market, 2018 – 2030 (USD Million)
4.3.4. Software
4.3.4.1. Software Market, 2018 – 2030 (USD Million)
4.4. Primary & Special Staining
4.4.1. Primary & Special Staining Market, 2018 – 2030 (USD Million)
4.5. Digital Pathology & Workflow
4.5.1. Digital Pathology & Workflow Market, 2018 – 2030 (USD Million)
4.5.2. Whole Slide Imaging
4.5.2.1. Whole Slide Imaging Market, 2018 – 2030 (USD Million)
4.5.3. Image Analysis Informatics
4.5.3.1. Image Analysis Informatics Market, 2018 – 2030 (USD Million)
4.5.4. Information Management System Storage & Communication
4.5.4.1. Information Management System Storage & Communication Market, 2018 – 2030 (USD Million)
4.6. Anatomic Pathology
4.6.1. Anatomic Pathology Market, 2018 – 2030 (USD Million)
4.6.2. Instruments
4.6.2.1. Instruments Market, 2018 – 2030 (USD Million)
4.6.2.2. Microtomes & Cryostat Microtomes
4.6.2.2.1. Microtomes & Cryostat Microtomes Market, 2018 – 2030 (USD Million)
4.6.2.3. Tissue Processors
4.6.2.3.1. Tissue Processors Market, 2018 – 2030 (USD Million)
4.6.2.4. Automatic Strainers
4.6.2.4.1. Automatic Strainers Market, 2018 – 2030 (USD Million)
4.6.2.5. Other Products
4.6.2.5.1. Other Products Market, 2018 – 2030 (USD Million)
4.6.3. Consumables
4.6.3.1. Consumables Market, 2018 – 2030 (USD Million)
4.6.3.2. Antibodies & Reagents
4.6.3.2.1. Antibodies & Reagents Market, 2018 – 2030 (USD Million)
4.6.3.3. Probes & Kits
4.6.3.3.1. Probes & Kits Market, 2018 – 2030 (USD Million)
4.6.3.4. Others
4.6.3.4.1. Others Market, 2018 – 2030 (USD Million)
Chapter 5. Application Business Analysis
5.1. Tissue Diagnostics Market: Application Movement Analysis
5.2. Breast Cancer
5.2.1. Breast Cancer Market, 2018 – 2030 (USD Million)
5.3. Non-Small Cell Lung Cancer
5.3.1. Non-Small Cell Lung Cancer Market, 2018 – 2030 (USD Million)
5.4. Other Cancers
5.4.1. Other Cancers Technology Market, 2018 – 2030 (USD Million)
5.5. Gastric Cancer
5.5.1. Gastric Cancer Technology Market, 2018 – 2030 (USD Million)
Chapter 6. End-Use Business Analysis
6.1. Hospitals
6.1.1. Hospitals Market, 2018 – 2030 (USD Million)
6.2. Research Laboratories
6.2.1. Research Laboratories Market, 2018 – 2030 (USD Million)
6.3. Pharmaceutical Organizations
6.3.1. Pharmaceutical Organizations Market, 2018 – 2030 (USD Million)
6.4. CRO
6.4.1. CRO Market, 2018 – 2030 (USD Million)
Chapter 7. Regional Business Analysis
7.1. Tissue Diagnostics Market Share By Region, 2022 & 2030
7.2. North America
7.2.1. SWOT Analysis
7.2.2. North America Tissue Diagnostics Market, 2018 – 2030 (USD Million)
7.2.3. U.S.
7.2.3.1. Key Country Dynamics
7.2.3.2. Target Disease Prevalence
7.2.3.3. Competitive Scenario
7.2.3.4. Regulatory Framework
7.2.3.5. U.S. Tissue Diagnostics Market, 2018 – 2030 (USD Million)
7.2.4. Canada
7.2.4.1. Key Country Dynamics
7.2.4.2. Target Disease Prevalence
7.2.4.3. Competitive Scenario
7.2.4.4. Regulatory Framework
7.2.4.5. Canada Tissue Diagnostics Market, 2018 – 2030 (USD Million)
7.3. Europe
7.3.1. SWOT Analysis
7.3.2. Europe Tissue Diagnostics Market, 2018 – 2030 (USD Million)
7.3.3. UK
7.3.3.1. Key Country Dynamics
7.3.3.2. Target Disease Prevalence
7.3.3.3. Competitive Scenario
7.3.3.4. Regulatory Framework
7.3.3.5. UK Tissue Diagnostics Market, 2018 – 2030 (USD Million)
7.3.4. Germany
7.3.4.1. Key Country Dynamics
7.3.4.2. Target Disease Prevalence
7.3.4.3. Competitive Scenario
7.3.4.4. Regulatory Framework
7.3.4.5. Germany Tissue Diagnostics Market, 2018 – 2030 (USD Million)
7.3.5. Spain
7.3.5.1. Key Country Dynamics
7.3.5.2. Target Disease Prevalence
7.3.5.3. Competitive Scenario
7.3.5.4. Regulatory Framework
7.3.5.5. Spain Tissue Diagnostics Market, 2018 – 2030 (USD Million)
7.3.6. France
7.3.6.1. Key Country Dynamics
7.3.6.2. Target Disease Prevalence
7.3.6.3. Competitive Scenario
7.3.6.4. Regulatory Framework
7.3.6.5. France Tissue Diagnostics Market, 2018 – 2030 (USD Million)
7.3.7. Italy
7.3.7.1. Key Country Dynamics
7.3.7.2. Target Disease Prevalence
7.3.7.3. Competitive Scenario
7.3.7.4. Regulatory Framework
7.3.7.5. Italy Tissue Diagnostics Market, 2018 – 2030 (USD Million)
7.3.8. Denmark
7.3.8.1. Key Country Dynamics
7.3.8.2. Target Disease Prevalence
7.3.8.3. Competitive Scenario
7.3.8.4. Regulatory Framework
7.3.8.5. Denmark Tissue Diagnostics Market, 2018 – 2030 (USD Million)
7.3.9. Sweden
7.3.9.1. Key Country Dynamics
7.3.9.2. Target Disease Prevalence
7.3.9.3. Competitive Scenario
7.3.9.4. Regulatory Framework
7.3.9.5. Sweden Tissue Diagnostics Market, 2018 – 2030 (USD Million)
7.3.10. Norway
7.3.10.1. Key Country Dynamics
7.3.10.2. Target Disease Prevalence
7.3.10.3. Competitive Scenario
7.3.10.4. Regulatory Framework
7.3.10.5. Norway Tissue Diagnostics Market, 2018 – 2030 (USD Million)
7.4. Asia Pacific
7.4.1. SWOT Analysis
7.4.2. Asia Pacific Tissue Diagnostics Market, 2018 – 2030 (USD Million)
7.4.3. Japan
7.4.3.1. Key Country Dynamics
7.4.3.2. Target Disease Prevalence
7.4.3.3. Competitive Scenario
7.4.3.4. Regulatory Framework
7.4.3.5. Japan Tissue Diagnostics Market, 2018 – 2030 (USD Million)
7.4.4. China
7.4.4.1. Key Country Dynamics
7.4.4.2. Target Disease Prevalence
7.4.4.3. Competitive Scenario
7.4.4.4. Regulatory Framework
7.4.4.5. China Tissue Diagnostics Market, 2018 – 2030 (USD Million)
7.4.5. India
7.4.5.1. Key Country Dynamics
7.4.5.2. Target Disease Prevalence
7.4.5.3. Competitive Scenario
7.4.5.4. Regulatory Framework
7.4.5.5. India Tissue Diagnostics Market, 2018 – 2030 (USD Million)
7.4.6. South Korea
7.4.6.1. Key Country Dynamics
7.4.6.2. Target Disease Prevalence
7.4.6.3. Competitive Scenario
7.4.6.4. Regulatory Framework
7.4.6.5. South Korea Tissue Diagnostics Market, 2018 – 2030 (USD Million)
7.4.7. Singapore
7.4.7.1. Key Country Dynamics
7.4.7.2. Target Disease Prevalence
7.4.7.3. Competitive Scenario
7.4.7.4. Regulatory Framework
7.4.7.5. Singapore Tissue Diagnostics Market, 2018 – 2030 (USD Million)
7.4.8. Australia
7.4.8.1. Key Country Dynamics
7.4.8.2. Target Disease Prevalence
7.4.8.3. Competitive Scenario
7.4.8.4. Regulatory Framework
7.4.8.5. Australia Tissue Diagnostics Market, 2018 – 2030 (USD Million)
7.4.9. Thailand
7.4.9.1. Key Country Dynamics
7.4.9.2. Target Disease Prevalence
7.4.9.3. Competitive Scenario
7.4.9.4. Regulatory Framework
7.4.9.5. Thailand Tissue Diagnostics Market, 2018 – 2030 (USD Million)
7.5. Latin America
7.5.1. SWOT Analysis
7.5.2. Latin America Tissue Diagnostics Market, 2018 – 2030 (USD Million)
7.5.3. Brazil
7.5.3.1. Key Country Dynamics
7.5.3.2. Target Disease Prevalence
7.5.3.3. Competitive Scenario
7.5.3.4. Regulatory Framework
7.5.3.5. Brazil Tissue Diagnostics Market, 2018 – 2030 (USD Million)
7.5.4. Mexico
7.5.4.1. Key Country Dynamics
7.5.4.2. Target Disease Prevalence
7.5.4.3. Competitive Scenario
7.5.4.4. Regulatory Framework
7.5.4.5. Mexico Tissue Diagnostics Market, 2018 – 2030 (USD Million)
7.5.5. Argentina
7.5.5.1. Key Country Dynamics
7.5.5.2. Target Disease Prevalence
7.5.5.3. Competitive Scenario
7.5.5.4. Regulatory Framework
7.5.5.5. Argentina Tissue Diagnostics Market, 2018 – 2030 (USD Million)
7.6. MEA
7.6.1. SWOT Analysis
7.6.2. MEA Tissue Diagnostics Market, 2018 – 2030 (USD Million)
7.6.3. South Africa
7.6.3.1. Key Country Dynamics
7.6.3.2. Target Disease Prevalence
7.6.3.3. Competitive Scenario
7.6.3.4. Regulatory Framework
7.6.3.5. South Africa Tissue Diagnostics Market, 2018 – 2030 (USD Million)
7.6.4. UAE
7.6.4.1. Key Country Dynamics
7.6.4.2. Target Disease Prevalence
7.6.4.3. Competitive Scenario
7.6.4.4. Regulatory Framework
7.6.4.5. UAE Tissue Diagnostics Market, 2018 – 2030 (USD Million)
7.6.5. Saudi Arabia
7.6.5.1. Key Country Dynamics
7.6.5.2. Target Disease Prevalence
7.6.5.3. Competitive Scenario
7.6.5.4. Regulatory Framework
7.6.5.5. Saudi Arabia Tissue Diagnostics Market, 2018 – 2030 (USD Million)
7.6.6. Kuwait
7.6.6.1. Key Country Dynamics
7.6.6.2. Target Disease Prevalence
7.6.6.3. Competitive Scenario
7.6.6.4. Regulatory Framework
7.6.6.5. Kuwait Tissue Diagnostics Market, 2018 – 2030 (USD Million)
Chapter 8. Competitive Landscape
8.1. Company Categorization
8.2. Strategy Mapping
8.3. Company Market Share Analysis, 2022
8.4. Company Profiles/Listing
8.4.1. F. Hoffmann-La Roche Ltd.
8.4.1.1. Overview
8.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.1.3. Technology Benchmarking
8.4.1.4. Strategic Initiatives
8.4.2. Abbott Laboratories
8.4.2.1. Overview
8.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.2.3. Technology Benchmarking
8.4.2.4. Strategic Initiatives
8.4.3. Thermo Fisher Scientific, Inc.
8.4.3.1. Overview
8.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.3.3. Technology Benchmarking
8.4.3.4. Strategic Initiatives
8.4.4. Siemens
8.4.4.1. Overview
8.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.4.3. Technology Benchmarking
8.4.4.4. Strategic Initiatives
8.4.5. Danaher Corporation
8.4.5.1. Overview
8.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.5.3. Technology Benchmarking
8.4.5.4. Strategic Initiatives
8.4.6. bioMerieux SA
8.4.6.1. Overview
8.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.6.3. Technology Benchmarking
8.4.6.4. Strategic Initiatives
8.4.7. QIAGEN
8.4.7.1. Overview
8.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.7.3. Technology Benchmarking
8.4.7.4. Strategic Initiatives
8.4.8. BD
8.4.8.1. Overview
8.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.8.3. Technology Benchmarking
8.4.8.4. Strategic Initiatives
8.4.9. Merck KGaA
8.4.9.1. Overview
8.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.9.3. Technology Benchmarking
8.4.9.4. Strategic Initiatives
8.4.10. GE Healthcare
8.4.10.1. Overview
8.4.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.10.3. Technology Benchmarking
8.4.10.4. Strategic Initiatives
8.4.11. BioGenex
8.4.11.1. Overview
8.4.11.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.11.3. Technology Benchmarking
8.4.11.4. Strategic Initiatives
8.4.12. Cell Signaling Technology, Inc.
8.4.12.1. Overview
8.4.12.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.12.3. Technology Benchmarking
8.4.12.4. Strategic Initiatives
8.4.13. Bio SB
8.4.13.1. Overview
8.4.13.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.13.3. Technology Benchmarking
8.4.13.4. Strategic Initiatives
8.4.14. DiaGenic ASA
8.4.14.1. Overview
8.4.14.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.14.3. Technology Benchmarking
8.4.14.4. Strategic Initiatives
8.4.15. Agilent Technologies, Inc
8.4.15.1. Overview
8.4.15.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.15.3. Technology Benchmarking
8.4.15.4. Strategic Initiatives

List of Tables

Table 1 List of abbreviations
Table 2 North America Tissue Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
Table 3 North America Tissue Diagnostics Market, by Application, 2018 - 2030 (USD Million)
Table 4 North America Tissue Diagnostics Market, by End-use, 2018 - 2030 (USD Million)
Table 5 North America tissue diagnostics market, by region, 2018 - 2030 (USD Million)
Table 6 U.S. Tissue Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
Table 7 U.S. Tissue Diagnostics Market, by Application, 2018 - 2030 (USD Million)
Table 8 U.S. Tissue Diagnostics Market, by End-use, 2018 - 2030 (USD Million)
Table 9 Canada Tissue Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
Table 10 Canada Tissue Diagnostics Market, by Application, 2018 - 2030 (USD Million)
Table 11 Canada Tissue Diagnostics Market, by End-use, 2018 - 2030 (USD Million)
Table 12 Europe Tissue Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
Table 13 Europe Tissue Diagnostics Market, by Application, 2018 - 2030 (USD Million)
Table 14 Europe Tissue Diagnostics Market, by End-use, 2018 - 2030 (USD Million)
Table 15 Europe tissue diagnostics market, by region, 2018 - 2030 (USD Million)
Table 16 UK Tissue Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
Table 17 UK Tissue Diagnostics Market, by Application, 2018 - 2030 (USD Million)
Table 18 UK Tissue Diagnostics Market, by End-use, 2018 - 2030 (USD Million)
Table 19 Germany Tissue Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
Table 20 Germany Tissue Diagnostics Market, by Application, 2018 - 2030 (USD Million)
Table 21 Germany Tissue Diagnostics Market, by End-use, 2018 - 2030 (USD Million)
Table 22 Spain Tissue Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
Table 23 Spain Tissue Diagnostics Market, by Application, 2018 - 2030 (USD Million)
Table 24 Spain Tissue Diagnostics Market, by End-use, 2018 - 2030 (USD Million)
Table 25 France Tissue Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
Table 26 France Tissue Diagnostics Market, by Application, 2018 - 2030 (USD Million)
Table 27 France Tissue Diagnostics Market, by End-use, 2018 - 2030 (USD Million)
Table 28 Italy Tissue Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
Table 29 Italy Tissue Diagnostics Market, by Application, 2018 - 2030 (USD Million)
Table 30 Italy Tissue Diagnostics Market, by End-use, 2018 - 2030 (USD Million)
Table 31 Denmark Tissue Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
Table 32 Denmark Tissue Diagnostics Market, by Application, 2018 - 2030 (USD Million)
Table 33 Denmark Tissue Diagnostics Market, by End-use, 2018 - 2030 (USD Million)
Table 34 Sweden Tissue Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
Table 35 Sweden Tissue Diagnostics Market, by Application, 2018 - 2030 (USD Million)
Table 36 Sweden Tissue Diagnostics Market, by End-use, 2018 - 2030 (USD Million)
Table 37 Norway Tissue Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
Table 38 Norway Tissue Diagnostics Market, by Application, 2018 - 2030 (USD Million)
Table 39 Norway Tissue Diagnostics Market, by End-use, 2018 - 2030 (USD Million)
Table 40 Asia Pacific Tissue Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
Table 41 Asia Pacific Tissue Diagnostics Market, by Application, 2018 - 2030 (USD Million)
Table 42 Asia Pacific Tissue Diagnostics Market, by End-use, 2018 - 2030 (USD Million)
Table 43 Asia Pacific tissue diagnostics market, by region, 2018 - 2030 (USD Million)
Table 44 Japan Tissue Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
Table 45 Japan Tissue Diagnostics Market, by Application, 2018 - 2030 (USD Million)
Table 46 Japan Tissue Diagnostics Market, by End-use, 2018 - 2030 (USD Million)
Table 47 China Tissue Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
Table 48 China Tissue Diagnostics Market, by Application, 2018 - 2030 (USD Million)
Table 49 China Tissue Diagnostics Market, by End-use, 2018 - 2030 (USD Million)
Table 50 India Tissue Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
Table 51 India Tissue Diagnostics Market, by Application, 2018 - 2030 (USD Million)
Table 52 India Tissue Diagnostics Market, by End-use, 2018 - 2030 (USD Million)
Table 53 South Korea Tissue Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
Table 54 South Korea Tissue Diagnostics Market, by Application, 2018 - 2030 (USD Million)
Table 55 South Korea Tissue Diagnostics Market, by End-use, 2018 - 2030 (USD Million)
Table 56 Singapore Tissue Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
Table 57 Singapore Tissue Diagnostics Market, by Application, 2018 - 2030 (USD Million)
Table 58 Singapore Tissue Diagnostics Market, by End-use, 2018 - 2030 (USD Million)
Table 59 Australia Tissue Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
Table 60 Australia Tissue Diagnostics Market, by Application, 2018 - 2030 (USD Million)
Table 61 Australia Tissue Diagnostics Market, by End-use, 2018 - 2030 (USD Million)
Table 62 Thailand Tissue Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
Table 63 Thailand Tissue Diagnostics Market, by Application, 2018 - 2030 (USD Million)
Table 64 Thailand Tissue Diagnostics Market, by End-use, 2018 - 2030 (USD Million)
Table 65 Latin America Tissue Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
Table 66 Latin America Tissue Diagnostics Market, by Application, 2018 - 2030 (USD Million)
Table 67 Latin America Tissue Diagnostics Market, by End-use, 2018 - 2030 (USD Million)
Table 68 Latin America tissue diagnostics market, by region, 2018 - 2030 (USD Million)
Table 69 Brazil Tissue Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
Table 70 Brazil Tissue Diagnostics Market, by Application, 2018 - 2030 (USD Million)
Table 71 Brazil Tissue Diagnostics Market, by End-use, 2018 - 2030 (USD Million)
Table 72 Mexico Tissue Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
Table 73 Mexico Tissue Diagnostics Market, by Application, 2018 - 2030 (USD Million)
Table 74 Mexico Tissue Diagnostics Market, by End-use, 2018 - 2030 (USD Million)
Table 75 Argentina Tissue Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
Table 76 Argentina Tissue Diagnostics Market, by Application, 2018 - 2030 (USD Million)
Table 77 Argentina Tissue Diagnostics Market, by End-use, 2018 - 2030 (USD Million)
Table 78 Middle East and Africa Tissue Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
Table 79 Middle East and Africa Tissue Diagnostics Market, by Application, 2018 - 2030 (USD Million)
Table 80 Middle East and Africa Tissue Diagnostics Market, by End-use, 2018 - 2030 (USD Million)
Table 81 Middle East and Africa tissue diagnostics market, by region, 2018 - 2030 (USD Million)
Table 82 South Africa Tissue Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
Table 83 South Africa Tissue Diagnostics Market, by Application, 2018 - 2030 (USD Million)
Table 84 South Africa Tissue Diagnostics Market, by End-use, 2018 - 2030 (USD Million)
Table 85 Saudi Arabia Tissue Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
Table 86 Saudi Arabia Tissue Diagnostics Market, by Application, 2018 - 2030 (USD Million)
Table 87 Saudi Arabia Tissue Diagnostics Market, by End-use, 2018 - 2030 (USD Million)
Table 88 UAE Tissue Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
Table 89 UAE Tissue Diagnostics Market, by Application, 2018 - 2030 (USD Million)
Table 90 UAE Tissue Diagnostics Market, by End-use, 2018 - 2030 (USD Million)
Table 91 Kuwait Tissue Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
Table 92 Kuwait Tissue Diagnostics Market, by Application, 2018 - 2030 (USD Million)
Table 93 Kuwait Tissue Diagnostics Market, by End-use, 2018 - 2030 (USD Million)

★調査レポート[組織診断の世界市場2023-2030：市場規模、シェア、動向分析] (コード：GRV23SEP068)販売に関する免責事項を必ずご確認ください。
★調査レポート[組織診断の世界市場2023-2030：市場規模、シェア、動向分析]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 組織診断の世界市場2023-2030：市場規模、シェア、動向分析
  • 鎌状赤血球症治療の世界市場2023-2030：市場規模、シェア、動向分析
  • 鎌状赤血球症治療の世界市場2023-2030：市場規模、シェア、動向分析
  • 血液検査の世界市場2023-2030：市場規模、シェア、動向分析
  • 血液検査の世界市場2023-2030：市場規模、シェア、動向分析
  • ガラス化の世界市場2023-2030：市場規模、シェア、動向分析
  • ガラス化の世界市場2023-2030：市場規模、シェア、動向分析
  • 着床前遺伝子検査（PGT）の世界市場2023-2030：市場規模、シェア、動向分析
  • 着床前遺伝子検査（PGT）の世界市場2023-2030：市場規模、シェア、動向分析
  • HPV検査＆パップテストの世界市場2023-2030：市場規模、シェア、動向分析

    • ◆H&Iグローバルリサーチのお客様（例）◆